Although apoA2-ATQ/AT can diagnose pancreatic cancer in the early stages or pancreatic cancer development from IPMN, the CLIA for EphA2-NF is superior to that of apoA2-ATQ/AT. This evidence concerns the gene APOA2 and pancreatic neoplasm.